IACP Breaking News
Meningitis Outbreak Update
10/11/2012 -- According to the Centers for Disease Control (CDC), the fungal meningitis crisis has left 14 people dead and 137 others infected in 10 states. The outbreak is linked to tainted methylprednisolone acetate steroid injections from the New England Compounding Center (NECC) in Framingham, Mass. Contaminants were found in an unopened vial during an inspection of NECC. Three lots of single-dose vials (17,676 single vials) of methylprednisolone acetate were sent to 76 facilities in 23 states were recalled.
States with reported infections
Florida (six cases, one death), Indiana (15 cases), Maryland (nine cases, one death), Michigan (28 cases, three deaths), Minnesota (three cases), North Carolina (two cases), Ohio (one case), Tennessee (44 cases, six deaths) Virginia (27 cases, one death) and New Jersey (two cases).
States that received injections
California, Connecticut, Florida, Georgia, Idaho, Illinois, Indiana, Maryland, Michigan, Minnesota, North Carolina, New Hampshire, New Jersey, Nevada, New York, Ohio, Pennsylvania, Rhode Island, South Carolina, Tennessee, Virginia, Texas and West Virginia.
The Centers for Disease Control and Prevention (CDC) as well as the Food & Drug Administration (FDA) currently are investigating the situation. To date, an official report on the exact cause has not been released.
Latest information on Fungal Meningitis Outbreak Investigation from CDC
FDA Statement on Fungal Meningitis Outbreak
Press Release - IACP Responds to Meningitis Outbreak Tied to Compounding Pharmacy
IACP Member Alert – Fungal Meningitis Outbreak
IACP Member Alert – Update on Fungal Meningitis Outbreak
In the Media
Meningitis outbreak: What is a compounding pharmacy?
Medicine implicated in rare meningitis cases went to 23 states
As the Toll in the Meningitis Outbreak Rises
Dr. Nancy Snyderman, NBC News Chief Medical Correspondent, Supports Pharmacy Compounding on TODAY Show
Tainted Steroid Injections And Public Health – The Diane Rehm Show
IACP will work to keep its members apprised of any developments on the fungal meningitis crisis.
Return to IACP Home Page